查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499536

大鼠和小鼠模型市场：按模型类型、技术、服务、治疗领域和最终用户划分 - 全球预测 2024-2030

Rat & Mouse Model Market by Model Type, Technology, Service, Therapeutic Area, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

大鼠和小鼠模型市场规模预计2023年为22.7亿美元，2024年达24.5亿美元，预计2030年将达到39.7亿美元，复合年增长率为8.26%。

大鼠和小鼠模型是生物医学研究的基本工具，可作为研究人类生理、遗传学、药理学和疾病发病机制的类似物。这些模型是专门培育的囓齿动物，用于了解疾病机制、评估药物的有效性以及评估遗传对健康和疾病的贡献。大鼠和小鼠模型的选择是基于研究目的，每种模型在遗传学、体型以及与人类的生理相似性方面都有自己的优势。 CRISPR/Cas9技术和其他基因工程工具的创新显着提高了创建基因改造大鼠和小鼠模型的准确性和效率。政府机构、非营利组织和私营部门对生物医学研究活动（包括大鼠和小鼠模型的开发和使用）的资助大幅增加。然而，替代研究方法（例如晶片器官和电脑建模）的发展和改进可能会减少某些类型的研究对动物模型的依赖。此外，许多人类疾病是多因素且复杂的，因此很难在大鼠或小鼠模型中完全重现人类病理学。由于遗传背景、环境条件和调查方法的差异，导致研究的可重复性变得复杂。领先的研究人员正在探索基因工程的进展，为创建更准确和疾病特异性的大鼠和小鼠模型提供了机会。将大鼠和小鼠模型与高通量定序和生物资讯学等新技术相结合，为详细的遗传分析和理解疾病机制开闢了新的途径。

主要市场统计
基准年[2023] 22.7亿美元
预测年份 [2024] 24.5亿美元
预测年份 [2030] 39.7亿美元
复合年增长率（%） 8.26%

区域洞察

美洲，特别是美国和加拿大，拥有强大的生物医学研究生态系统，并得到医疗保健和药物研发 (R&D) 的大量投资的支持。这些地区的消费者正在影响他们对基因工程和 CRISPR 基因编辑模型的购买行为，因为他们优先考虑提供精确性和可重复性的模型。美国的研究计画和专利重点关注基因工程、CRISPR 技术和个人化医疗应用的创新。美国国立卫生研究院 (NIH) 支持疾病建模研究，特别是癌症、神经退化性疾病和心血管疾病的研究。欧盟 (EU) 国家因其成熟的製药和生物技术产业以及高标准的医疗保健研究而表现出对大鼠和小鼠模型的强烈需求。欧盟的监管框架和资助机制，包括“地平线欧洲”，促进了遗传学、肿瘤学和神经退化研究的研究和创新。欧盟消费者的需求集中在研究中动物的道德采购和使用、促进替代方案以及大鼠和小鼠模型的有效使用。消费者运动受到严格指导方针的监管，以确保研究动物的福利和道德待遇。以中国、日本和印度为代表的亚太地区是大鼠模型发展最快的地区。支持这一增长的是对药物研发、基因研究的投资增加以及对个人化医疗日益增长的兴趣。中国市场得到了政府在生物技术和药物开发领域的大量投资以及基因工程专业知识不断增长的支持。日本拥有先进的医疗保健系统，并且专注于针对老龄化人口的创新治疗，因此强调神经退化和心血管研究的模型。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在大鼠和小鼠模型市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对大鼠和小鼠模型市场中供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在大鼠和小鼠模型市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对基因工程模型来检验治疗标靶的庞大需求
      • 增加製药和生技领域研发活动的支出
      • 个人化医疗需求快速成长
    • 抑制因素
      • 大鼠和小鼠模型的伦理问题和局限性
    • 机会
      • 致力于充满人性的主题
      • 不断发展的治疗研究领域
    • 任务
      • 替代测试方法的存在
  • 市场区隔分析
    • 模型类型：对基因转殖大鼠带来的遗传功能和遗传疾病发展的重要见解
    • 服务：由于需要产生特定的遗传背景，扩大了大鼠和小鼠模型在育种服务中的使用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依模型类型分類的大鼠和小鼠模型市场

  • 透过调节或手术改造的大鼠
  • 基因改造老鼠
  • 混合或同类大鼠
  • 免疫力缺乏大鼠
  • 近交系大鼠
  • 近交系大鼠

第七章大鼠和小鼠模型市场：依技术分类

  • 更脆的
  • 胚胎干细胞注射
  • 显微注射
  • 核转移

第八章大鼠模型市场：依服务分类

  • 配种
  • 冷冻保存
  • 基因检测
  • 引入授权的模型
  • 隔离
  • 衍生

第 9 章按治疗领域分類的大鼠和小鼠模型市场

  • 循环系统疾病
  • 糖尿病
  • 免疫学和发炎
  • 神经病学
  • 肿瘤学
  • 毒理学

第 10 章 大鼠和小鼠模型市场：依最终使用者分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章 北美和南美大鼠模型市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区大鼠模型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲大鼠模型市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Charles River 实验室利用先进的基因工程小鼠模型为临床前研究提供支持
    • 创新的小鼠模式为慢性淋巴性白血病和里氏转化的新治疗方法铺平了道路
    • 开拓小鼠模型来阐明 IL-6 在虚弱和老化中的作用
  • 战略分析和建议

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-3A2E844FF329

[193 Pages Report] The Rat & Mouse Model Market size was estimated at USD 2.27 billion in 2023 and expected to reach USD 2.45 billion in 2024, at a CAGR 8.26% to reach USD 3.97 billion by 2030.

Rat & mouse models are fundamental tools in biomedical research, serving as analogs for studying human physiology, genetics, pharmacology, and disease pathogenesis. These models have specifically bred rodents used to understand disease mechanisms, assess drug efficacy, and evaluate genetic contributions to health and disease. The choice between rat and mouse models is determined based on the research objectives, with each offering unique advantages in terms of genetics, size, and physiological similarities to humans. Innovations in CRISPR/Cas9 technology and other genetic manipulation tools have significantly improved the precision and efficiency of creating genetically modified rat and mouse models. There is a substantial rise in funding from government bodies, non-profit organizations, and the private sector towards biomedical research activities, including the development and use of rat and mouse models. However, the development and improvement of alternative research methods, such as organ-on-a-chip and computer modeling, might reduce reliance on animal models for some types of research. Furthermore, many human diseases are multifactorial and complex, making it challenging to fully replicate human pathologies in rat and mouse models. Ensuring the replicability of the studies is complicated by variability in genetic backgrounds, environmental conditions, and methodological differences. Key players are exploring ongoing advancements in genetic engineering and offering opportunities to create more accurate and disease-specific rat and mouse models. Combining rat and mouse models with emerging technologies, such as high-throughput sequencing and bioinformatics, opens new avenues for in-depth genetic analysis and understanding of disease mechanisms.

KEY MARKET STATISTICS
Base Year [2023] USD 2.27 billion
Estimated Year [2024] USD 2.45 billion
Forecast Year [2030] USD 3.97 billion
CAGR (%) 8.26%

Regional Insights

In the Americas, particularly in the United States and Canada, there is a robust ecosystem for biomedical research supported by substantial investments in healthcare and pharmaceutical research and development (R&D). Consumers in these regions prioritize models that offer precision and reproducibility, thus influencing purchasing behavior towards genetically engineered and CRISPR gene-edited models. Research initiatives and patents in the United States focus on innovations in genetic engineering, CRISPR technology, and personalized medicine applications. The National Institutes of Health (NIH) supports research in disease models, particularly for cancer, neurodegenerative diseases, and cardiovascular conditions. The European Union (EU) countries exhibit a strong need for rat and mouse models, driven by well-established pharmaceutical and biotech industries, alongside high standards for healthcare research. The EU's regulatory framework and funding mechanisms, including Horizon Europe, facilitate research and innovation in genetic, oncology, and neurodegenerative studies. Consumer demands in the EU focus on ethical sourcing and the use of animals in research, pushing for alternative methods and efficient use of rat and mouse models. Consumer dynamics is regulated by stringent guidelines that ensure the welfare and ethical treatment of research animals. The Asia Pacific region, led by China, Japan, and India, is a rapidly growing landscape for rat and mouse models. This growth is underpinned by increasing investments in pharmaceutical R&D, genetic research, and a rising focus on personalized medicine. China's market is propelled by significant government investment in biotechnology and drug development sectors, alongside growing expertise in genetic engineering. Japan, with its sophisticated healthcare system and a strong emphasis on innovative treatments for aging populations, places a premium on models for neurodegenerative and cardiovascular research.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Rat & Mouse Model Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Significant demand for genetically modified models to validate therapeutic targets
      • Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
      • Surge in demand for personalized medicine
    • Market Restraints
      • Ethical concerns and limitation of rat & mouse model
    • Market Opportunities
      • Inclination towards humanized rat & mouse model
      • Growing therapeutic research areas
    • Market Challenges
      • Presence of alternative testing methods
  • Market Segmentation Analysis
    • Model Type: Significant critical insights provided by genetically modified rats into genetic functions and pathogenesis of genetic diseases
    • Service: Expanding usage of rat and mouse models for breeding services due to the necessity to produce specific genetic backgrounds
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Rat & Mouse Model Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Rat & Mouse Model Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Enhancing Preclinical Research through Advanced Genetically Modified Mouse Models by Charles River Laboratories

Charles River Laboratories has significantly advanced its Triple-Immunodeficient Mouse Model Portfolio with the introduction of the NCG Plus series, focusing on enhancing preclinical research capabilities. The latest additions, NCG-hIL2 and NCG-hIL15, are engineered to express human cytokines, IL-2 and IL15, respectively, facilitating the expansion and activation of immune cells, crucial for in vivo studies. [Published On: 2024-01-11]

Innovative Mouse Model Paves Way for New Therapies in Chronic Lymphocytic Leukaemia and Richter Transformation

Researchers from Hospital Clinic-IDIBAPS have developed a groundbreaking mouse model that emulates the Richter transformation observed in chronic lymphocytic leukaemia (CLL) patients, marking a pivotal advancement in the pursuit of effective treatments for this aggressive lymphoma conversion. This transformative development hinges on the creation of patient-derived xenografts, employing cells from a CLL patient to establish the model that accurately represents the clinical progression and molecular dynamics of Richter transformation. [Published On: 2023-12-15]

Pioneering a Mouse Model to Elucidate the Role of IL-6 in Frailty and Aging

Johns Hopkins University School of Medicine researchers have advanced o understanding of frailty in aging mammals through the development of a novel mouse model. By genetically engineering middle-aged male mice to express the human IL-6 gene, the researchers have illuminated the complex effects of this protein on cellular mitochondria and overall physical decline. This innovative model offers a nuanced understanding of IL-6's dualistic role in inflammation and frailty, providing a valuable framework for future investigations into the molecular underpinnings of aging. [Published On: 2023-07-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Rat & Mouse Model Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Rat & Mouse Model Market, highlighting leading vendors and their innovative profiles. These include Allentown, Inc., Aragen Life Sciences, Biocytogen, Biomere Biomedical Research Models, Inc., Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc. by JSR Corp., Cyagen US Inc., Envigo by Inotiv, Inc., GemPharmatech, GenOway S.A., Harbour Biomed, Hera BioLabs, Ingenious Targeting Laboratory, Janvier Labs, Oncodesign Precision Medicine, Ozgene Pty Ltd., PerkinElmer, Inc., Pharmatest Services Oy, PolyGene AG, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, TransViragen, Inc., and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Rat & Mouse Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Model Type
    • Conditioned or Surgically Modified Rats
    • Genetically Modified Rats
    • Hybrid or Congenic Rats
    • Immunodeficient Rats
    • Inbred Rats
    • Outbred Rats
  • Technology
    • CRISPR
    • Embryonic Stem Cell Injection
    • Microinjection
    • Nuclear Transfer
  • Service
    • Breeding
    • Cryopreservation
    • Genetic Testing
    • Model-in-Licensing
    • Quarantine
    • Rederivation
  • Therapeutic Area
    • Cardiovascular Disease
    • Diabetes
    • Immunology & Inflammation
    • Neurology
    • Oncology
    • Toxicology
  • End-User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant demand for genetically modified models to validate therapeutic targets
      • 5.1.1.2. Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
      • 5.1.1.3. Surge in demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns and limitation of rat & mouse model
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination towards humanized rat & mouse model
      • 5.1.3.2. Growing therapeutic research areas
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative testing methods
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Model Type: Significant critical insights provided by genetically modified rats into genetic functions and pathogenesis of genetic diseases
    • 5.2.2. Service: Expanding usage of rat and mouse models for breeding services due to the necessity to produce specific genetic backgrounds
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Rat & Mouse Model Market, by Model Type

  • 6.1. Introduction
  • 6.2. Conditioned or Surgically Modified Rats
  • 6.3. Genetically Modified Rats
  • 6.4. Hybrid or Congenic Rats
  • 6.5. Immunodeficient Rats
  • 6.6. Inbred Rats
  • 6.7. Outbred Rats

7. Rat & Mouse Model Market, by Technology

  • 7.1. Introduction
  • 7.2. CRISPR
  • 7.3. Embryonic Stem Cell Injection
  • 7.4. Microinjection
  • 7.5. Nuclear Transfer

8. Rat & Mouse Model Market, by Service

  • 8.1. Introduction
  • 8.2. Breeding
  • 8.3. Cryopreservation
  • 8.4. Genetic Testing
  • 8.5. Model-in-Licensing
  • 8.6. Quarantine
  • 8.7. Rederivation

9. Rat & Mouse Model Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Disease
  • 9.3. Diabetes
  • 9.4. Immunology & Inflammation
  • 9.5. Neurology
  • 9.6. Oncology
  • 9.7. Toxicology

10. Rat & Mouse Model Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Rat & Mouse Model Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Rat & Mouse Model Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Rat & Mouse Model Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Enhancing Preclinical Research through Advanced Genetically Modified Mouse Models by Charles River Laboratories
    • 14.3.2. Innovative Mouse Model Paves Way for New Therapies in Chronic Lymphocytic Leukaemia and Richter Transformation
    • 14.3.3. Pioneering a Mouse Model to Elucidate the Role of IL-6 in Frailty and Aging
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RAT & MOUSE MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. RAT & MOUSE MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RAT & MOUSE MODEL MARKET DYNAMICS
  • FIGURE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RAT & MOUSE MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONDITIONED OR SURGICALLY MODIFIED RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONDITIONED OR SURGICALLY MODIFIED RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETICALLY MODIFIED RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETICALLY MODIFIED RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY HYBRID OR CONGENIC RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY HYBRID OR CONGENIC RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNODEFICIENT RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNODEFICIENT RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INBRED RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INBRED RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY OUTBRED RATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY OUTBRED RATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRISPR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRISPR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BREEDING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BREEDING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL-IN-LICENSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL-IN-LICENSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY QUARANTINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY QUARANTINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REDERIVATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REDERIVATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 241. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 251. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 261. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 282. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 283. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 290. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 291. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 292. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 293. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 299. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 300. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 301. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 302. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 303. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 309. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 310. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 311. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 312. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 313. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 318. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 319. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 320. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 321. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 322. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 323. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 328. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 329. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 330. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 331. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 332. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 333. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. ITALY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. ITALY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. ITALY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 338. ITALY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 339. ITALY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 340. ITALY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 341. ITALY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 342. ITALY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 343. ITALY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 344. ITALY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 345. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 350. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 351. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 352. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 353. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 354. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 355. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2023 (USD